News search

Anagha Jagannathan, Carlos Real Jiménez, Laura Cádiz, Sofía Trigo Anca, Anabel Díaz-Guerra Priego, Miguel Fernández Tocino, Carlos Galán Arriola, Borja Ibáñez, Agustín Clemente Moragón, Sandra Gomez, Ana Devesa, Juan Rene Delgado Cornejo, Danielle Medina-Hernandez, Warren Alexander Skoza, Lucía Pilar López Palomar, Nico Hoffmann, Carlos Caballero Henares and Ángela Pollán García.

Research

4 Feb 2025

JACC CardioOncology: CNIC scientists design an effective treatment strategy to prevent heart injury caused by a class of anticancer drugs

The study, published in JACC: CardioOncology, shows that administration of the SGLT2 inhibitor empagliflozin to pigs receiving anthracyclines preserves mitochondrial function, improves myocardial energetics, and prevents degenerative changes in heart structure

From left to right: D. MacGrogan, B. Flores-Garza, T. González-Costa, V. Sebastián-Serrano, J.L. de la Pompa, L. Méndez-Peralta, A. Pau-Navalón, A. Galicia-Martín, J. Santos-Cantador, C. Relaño-Ruperez, M. Siguero-Álvarez

About the CNIC

12 Dec 2024

CNIC participates in an international Leducq Foundation project investigating the connection between the placenta and the heart during embryonic development

The new project, ‘The Placenta in Maternal and Fetal Cardiovascular Health and Disease’, aims to understand how the placenta influences cardiovascular health in mothers and their children, promising improvements in the prevention and treatment of related diseases

El Dr. Valentín Fuster recibe el Premio de la Sociedad Internacional de Aterosclerosis

About the CNIC

5 Dec 2024

Valentin Fuster, wins prestigious award from the International Atherosclerosis Society

The International Atherosclerosis Society recognizes the contributions to the understanding and treatment of atherosclerosis by the director of the National Center for Cardiovascular Research (CNIC) and president of the Mount Sinai Fuster Heart

About the CNIC

30 Sep 2024

CNIC Joins the 2024 Heart Race

Cardiovascular risk factors (particularly metabolic syndrome, insulin resistance, and diabetes) alter coronary microvascular function and increase the risk of atherosclerotic disease, which itself leads to changes in the coronary microcirculation.

Research

19 Sep 2024

JACC: Cardiovascular Imaging: Cardiometabolic risk factors in apparently healthy individuals are linked to altered coronary microcirculation

A study from CNIC reveals how risk factors and subclinical atherosclerosis affect heart microcirculation in asymptomatic middle-aged individuals. The research, published in JACC: Cardiovascular Imaging, highlights the importance of assessing the heart vessels' ability to regulate blood flow and predict future cardiovascular risk

Research

13 Sep 2024

The RESILIENCE trial: preventing heart injury caused by anticancer drugs

RESILIENCE is a clinical trial funded by the European Commission (H2020 Programme) that aims to reduce the prevalence of heart failure in cancer survivors

About the CNIC

12 Sep 2024

Join CNIC through CURE HEART AND BRAIN (COFUND)

Research

30 Aug 2024

Nature Medicine: CNIC scientists discover a new cardiovascular risk factor and identify a drug able to reduce its effects

Two studies carried out at the CNIC provide key information about a newly identified cardiovascular risk factor, clonal hematopoiesis, and its treatment with the ancient medication colchicine